Jakob Brix Christensen
Directeur Général chez Unibio AS
Profil
Jakob Brix Christensen is currently the Co-Chief Executive Officer at Unibio.
AS since 2021.
Prior to this, he worked as the Director-Investor Relations at Origio A from 2007 to 2012, Senior Manager-Business Finance at Novozymes A from 2012 to 2013, Partner-Business Finance at Albumedix A from 2013 to 2015, and Chief Financial Officer at Bioporto A from 2016 to 2018.
Postes actifs de Jakob Brix Christensen
| Sociétés | Poste | Début |
|---|---|---|
Unibio AS
 Unibio AS BiotechnologyHealth Technology Unibio AS is a Danish biotechnology company that operates in an undisclosed location. The private company was founded in 2001, and its CEOs are Jakob Brix Christensen, Sten Bay Jørgensen, and David Richard Henstrom. | Directeur Général | 27/06/2021 |
Anciens postes connus de Jakob Brix Christensen
| Sociétés | Poste | Fin |
|---|---|---|
| BIOPORTO A/S | Directeur Financier/CFO | 01/06/2018 |
Albumedix A/S
 Albumedix A/S Pharmaceuticals: MajorHealth Technology Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark. | Corporate Officer/Principal | 01/12/2015 |
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | 01/04/2013 |
Origio A/S
 Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Public Communications Contact | 01/04/2012 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOPORTO A/S | Health Technology |
| Entreprise privées | 4 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Process Industries |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Health Technology |
Albumedix A/S
Albumedix A/S Pharmaceuticals: MajorHealth Technology Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark. | Health Technology |
Unibio AS
Unibio AS BiotechnologyHealth Technology Unibio AS is a Danish biotechnology company that operates in an undisclosed location. The private company was founded in 2001, and its CEOs are Jakob Brix Christensen, Sten Bay Jørgensen, and David Richard Henstrom. | Health Technology |
